Is VTRS Worth Buying in 2026?

Viatris Inc. Common Stock

STOCK PHARMACEUTICAL PREPARATIONS Updated 2026-07-26

Here’s whether Viatris Inc. Common Stock (VTRS) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bullish.

🟢
Bullish

Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+1.22% over 10 days); RSI 56 — healthy momentum range; strong 1-year return of +84.4%; 3-month momentum positive (+18.2%). Currently 2.5% off its 52-week high. Score: +7/7.

Ready to act on this? 📈 Trade on Webull

VTRS is in a confirmed uptrend, trading above both its 50-day ($16.38) and 200-day ($13.75) moving averages. An RSI of 55.6 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +84.4% compares to +16.5% for SPY (beat the market by 67.9%).

$10,000 invested 1 year ago → $18,439 today
vs. S&P 500 (SPY) — same period beat market by 67.9%

1-Year Price Chart

Daily candles
MA-50 MA-200 Up Down

Signal Check

Above 200-day MA ($13.75)
Above 50-day MA ($16.38)
RSI(14) neutral zone (30–70) — currently 55.6
Positive return (+84.4%)
Within 10% of period high (−2.5%)
Period Range $17.24
$8.63 $17.68
RSI (14) 55.6
0 · OversoldOverbought · 100

Key Metrics

Price$17.24
Period Return+84.4%
Period High$17.68
Period Low$8.63
Drawdown−2.5%
MA-50$16.38
MA-200$13.75
RSI (14)55.6
Avg Volume (30d)9.9M
vs. SPYbeat by 67.9%
Return Rank#131 of 999

Trade VTRS

📈 Trade on Webull 📊 Trade on moomoo 💹 Interactive Brokers